Explore more publications!

Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on March 2, 2026

The FDA Group Launches AICA, an AI-Powered Compliance Auditing Platform Purpose-Built for Life Sciences
Tilray Brands Acquires BrewDog, a Leading Global Craft Brand, Creating a ~$500 Million Global Craft Beer and Beverage Platform
Don’t Kidney Around This National Kidney Month, Get the Facts Your Kidneys Wish You Knew
Academy of Nutrition and Dietetics Celebrates Power of Nutrition for 2026 National Nutrition Month®
Health-ISAC Releases Its 2025 Annual Report
Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026
American Kidney Fund Brings Kidney Community Together March 2-5 for Seventh Annual Kidney Action Week
Interra Health, created through the merger of DoseSpot and Arrive Health, ushers in a new era of transparency for patients and providers
SAB BIO to Participate in Upcoming Investor Conferences
AIM ImmunoTech Signs Agreement for Planning of a Proposed Phase 3 Clinical Trial of Ampligen in the Treatment of Late-Stage Pancreatic Cancer
Palisade Bio Announces Participation in Two Upcoming Investor Conferences
Award-Winning Speaker Mike Veny Launches “Coffee with Mike” Mental Health Podcast for Workplace Leaders
MyFitnessPal Acquires Cal AI, Expanding on its Position as the Leading Player in Digital Nutrition Tracking
Oncolytics Biotech® Launches Randomized Colorectal Cancer Study
Ascendis Pharma to Participate in the TD Cowen 46th Annual Health Care Conference
Biomimetic Innovations Ltd Announces Upcoming Clinical Study of OsStic™ Injectable Synthetic Bone Void Filler in Tibial Plateau Fracture Fixation
Allogene Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update
CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
BioSyent Announces Closing of the Acquisition of Oral Science Inc.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions